Core Viewpoint - The article highlights the innovative journey of Aoyi Technology, which has developed the OHand™ smart bionic hand, enabling amputees to regain daily functionality and significantly impacting the rehabilitation industry [1][8]. Group 1: Company Background and Development - Aoyi Technology's CEO, Ni Hualiang, emphasizes the importance of meaningful and economically viable projects, which has guided the company's direction for ten years [1][4]. - The company began its journey in a basement in Toronto, where initial product development faced significant challenges, including limited resources and equipment [2][6]. - Ni Hualiang's transition from a stable job at Qualcomm to full-time entrepreneurship was catalyzed by an investor's advice, leading to a commitment to the company despite financial struggles [6][7]. Group 2: Product Innovation and Market Position - Aoyi Technology has developed a comprehensive technology platform integrating robotics, AI, and neural interfaces, resulting in products like the OHand™ series and ROHand series [8][11]. - The company aims to make high-performance bionic hands accessible to all, transitioning from luxury items to everyday necessities [15][20]. - Aoyi's entry into the Shanghai Rehabilitation Association's subsidy directory allows for significant reimbursement, making their products affordable for a broader audience [17][19]. Group 3: Industry Trends and Future Outlook - The bionic hand and dexterous hand technologies are positioned for explosive growth, with the potential for humanoid robots to evolve into multifunctional devices [11][12]. - Aoyi Technology's focus on cost control and self-sufficient production capabilities is expected to enhance product affordability and accessibility [19][20]. - The company is expanding its product line into more medical rehabilitation areas, including a new series of neuro-rehabilitation exoskeletons, addressing the needs of stroke patients [20][22].